Corrigendum: Efficacy and safety of darbepoetin alfa injection replacing epoetin alfa injection for the treatment of renal anemia in Chinese hemodialysis patients: A randomized, open-label, parallel-group, noninferiority phase Ⅲ trial  

出　　处：《Chronic Diseases and Translational Medicine》2024年第4期350-350,共1页慢性疾病与转化医学（英文版）

摘　　要：In the article titled,"Efficacy and safety of darbepoetin alfa injection replacing epoetin alfa injection for the treatment of renal anemia in Chinese hemodialysis patients:A randomized,open-label,parallel-group,noninferiority phase Il trial"published in pages 134-144,issue 2,vol.8 of Chronic Diseases and Translational Medicine,the information of trial registration at the end of Abstract is missing.The registration information should be:This study has been registered on www.chinadrugtrials.org.cn,registered number CTR20130079.

关 键 词：TREATMENT INJECTION registered 

分 类 号：R692.5[医药卫生—泌尿科学] G23[医药卫生—外科学]